Top 10 ai-driven startup funding rounds of the week

This week’s top 10 U.S. startup funding rounds highlight significant investments in AI and related sectors. Modal Labs led with a $750 million Series D round, reaching a $15.75 billion valuation, while Icon secured $200 million for its construction automation tech. Other notable deals include Soufflé Therapeutics’ $135 million in RNA therapies and Estuary Biotherapeutics’ $103 million for gene therapies. Labelbox raised $100 million for AI tools, and Suki, a health AI provider, closed a $90 million Series E. Abby Care, Stand, Mueon, and North.cloud also secured substantial funding. These deals, reported between Oct. 10-16, 2026, reflect continued growth in late-stage and seed funding. The Crunchbase Megadeals Board tracks these rounds, offering insights into the latest AI-driven startup activity. The funding landscape shows a surge in both late-stage and seed investments, with AI infrastructure, construction tech, and biotech leading the charge. Companies like Modal Labs and Icon are capitalizing on their growth, with Modal Labs recently surpassing an annual revenue run rate of $1 billion. Meanwhile, Icon aims for 4x revenue growth in 2026. These developments underscore the ongoing momentum in AI and adjacent industries, with investors showing sustained interest in high-potential startups.